Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dexamethasone does not interfere with hormone-sensitive PI hydrolysis.

F S London1, R Caamano-Haigh, K P Chepenik

  • 1Department of Anatomy, Thomas Jefferson University, Philadelphia, Pennsylvania 19107.

Teratology
|February 1, 1989
PubMed
Summary

Serum stimulates inositol phosphate release in human embryo palate mesenchyme cells. Dexamethasone (DEX) does not affect this signaling but may influence phosphoinositide synthesis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Binding studies of the enzyme (factor IXa) with the cofactor (factor VIIIa) in the assembly of factor-X activating complex on the activated platelet surface.

Journal of thrombosis and haemostasis : JTH·2003
Same author

The assembly of the factor X-activating complex on activated human platelets.

Journal of thrombosis and haemostasis : JTH·2003
Same author

Guanylyl cyclases and signaling by cyclic GMP.

Pharmacological reviews·2000
Same author

Zymogen factor IX potentiates factor IXa-catalyzed factor X activation.

Biochemistry·2000
Same author

Differential regulation of cyclooxygenases 1 and 2 by interleukin-1 beta, tumor necrosis factor-alpha, and transforming growth factor-beta 1 in human lung fibroblasts.

Experimental cell research·1998
Same author

Developmental regulation of various annexins in the embryonic palate of the mouse: dexamethasone affects expression of annexin-1.

Journal of craniofacial genetics and developmental biology·1995

Area of Science:

  • Cell Biology
  • Biochemistry
  • Developmental Biology

Background:

  • Inositol lipid metabolism is crucial for transmembrane signaling.
  • Glucocorticoids like dexamethasone (DEX) can modulate cellular processes.
  • Understanding signaling pathways in embryonic cells is vital for developmental research.

Purpose of the Study:

  • To investigate the effect of serum and epidermal growth factor (EGF) on inositol phosphate release in human embryo palate mesenchyme (HEPM) cells.
  • To determine whether dexamethasone (DEX) interferes with serum-induced inositol lipid signaling.
  • To explore DEX's impact on phospholipase C activity and phosphoinositide synthesis in mouse embryo palate mesenchyme (MEPM) cells.

Main Methods:

  • HEPM cells were prelabeled with [3H]-myoinositol to track inositol phosphate release.

Related Experiment Videos

  • Cells were treated with serum, EGF, and varying concentrations of dexamethasone (DEX).
  • Proliferation assays and measurements of [3H]-myoinositol incorporation into membrane lipids were performed.

    • Main Results:

    • Serum, but not EGF, stimulated the release of radiolabeled inositol phosphates from HEPM cells.
    • DEX pretreatment did not alter serum-induced inositol phosphate release in HEPM cells.
    • DEX inhibited MEPM cell proliferation but did not affect phospholipase C activity, yet enhanced [3H]-myoinositol incorporation into membrane lipids.

    Conclusions:

    • Serum factors enhance inositol lipid metabolism in HEPM cells, indicating a role in transmembrane signaling.
    • DEX does not disrupt the primary signaling events mediated by inositol lipid metabolism.
    • DEX may influence the synthesis of phosphoinositides, suggesting a regulatory role in membrane lipid composition.